Quantification of Motor Learning in Hand Adjustability Movements: An Evaluation Variable for Discriminant Cognitive Decline

Abstract

Objective: Mild cognitive impairment (MCI) is characterized by early symptoms of attentional decline and may be distinguished through motor learning results. A relationship was reported between dexterous hand movements and cognitive function in older adults. Therefore, this study focuses on motor learning involving dexterous hand movements. As motor learning engages two distinct types of attention, external and internal, we aimed to develop an evaluation method that separates these attentional functions within motor learning. The objective of this study was to develop and verify the effectiveness of this evaluation method. The effectiveness was assessed by comparing two motor learning variables between a normal cognitive (NC) and MCI groups. Method: To evaluate motor learning through dexterous hand movements, we utilized the iWakka device. Two types of visual tracking tasks, repeat and random, were designed to evaluate motor learning from different aspects. The tracking errors in both tasks were quantitatively measured, and the initial and final improvement rates during motor learning were defined as the evaluation variables. The study included 28 MCI participants and 40 NC participants, and the effectiveness of the proposed method was verified by comparing results between the groups. Results: The repeat task revealed a significantly lower learning rate in MCI participants (p <0.01). In contrast, no significant difference was observed between MCI and NC participants in the random task (p =0.67). Conclusion: The evaluation method proposed in this study demonstrated the possibility of obtaining evaluation variables that indicate the characteristics of MCI. Clinical Impact: The methods proposed in this work are clinically relevant because the proposed evaluation system can make evaluation variables for discriminating cognitive decline in MCI. That it, the proposed approach can also be used to provide discrimination for cognitive decline in MCI.